Flomics
1 known investors
Find your way into Flomics
296 people in our graph share verified history with the Flomics team — schools, employers, funds. One of them is your warm intro.
Mar Fernándezunlockedknows João Curado · together at Universitat de Barcelona (overlapped)
×6knows the team · via Harvard Medical School
knows the team · via Universitat de Barcelona
×2knows the team · via Instituto Superior Técnico
×2knows the team · via Universidade do Porto
Flomics develops liquid biopsy tests using next-generation sequencing and machine learning to detect cancer and other complex diseases from blood samples for clinical diagnostics. The company also provides end-to-end genomics solutions including data generation, analysis, and bioinformatics support for research and clinical projects.
Founders & leadership
JC
João CuradoinCEO & Co-founderJoão Curado is CEO and co-founder of Flomics, a liquid biopsy company developing next-generation sequencing and machine learning-based tests for cancer and disease detection from blood samples. He has expertise in genomics, bioinformatics, and statistical analysis, with a background in academic research.
EL
Esther LizanoScientific Advisor & Co-founder
LK
Luís KorrodiinBusiness Advisor & Co-founderBusiness Advisor and co-founder of Flomics, which develops next-generation sequencing and machine learning-based liquid biopsy tests for cancer and disease diagnostics alongside end-to-end genomics services. He holds a PhD in Biochemistry and a Master's in Business Management applied to Project Management, with experience in healthcare and business development.
AG
André GuedesinCOO & Co-founderAndré Guedes holds a PhD in Physics and has built technology companies in biotech and deep tech, with experience in operations, partnerships, and fundraising across Europe and Silicon Valley. He is co-founder and COO of Flomics, which develops liquid biopsy tests using sequencing and machine learning to detect cancer and other complex diseases from blood samples.
Investors · 1
In the news
Frequently asked questions
- What does Flomics do?
- Flomics develops liquid biopsy tests using next-generation sequencing and machine learning to detect cancer and other complex diseases from blood samples for clinical diagnostics. The company also provides end-to-end genomics solutions including data generation, analysis, and bioinformatics support for research and clinical projects.
- Who founded Flomics?
- Flomics was founded by João Curado, Esther Lizano, Luís Korrodi, André Guedes.
- Who are Flomics's investors?
- Flomics's investors include Capital Cell.